A company that helps dogs overcome lameless and restore mobility through 3D printing, has received a six-figure investment.
Fusion Implants, a biotech start-up company based in the UK, has recently received a six-figure investment to develop and market its products. The company has developed orthopaedic metal implants, using its patented 3-D printing technology, which provides much greater design freedom than conventional manufacturing techniques, and also allows them to combine solid and porous sections for optimum strength and biological performance. Their lead implant, which is for use in canine knee reconstructions, is already on the market and is being sold to veterinary practices.
The company is a synergy of the skills and expertise of engineers – Dr. Dan Jones and Dr. Chris Sutcliffe, and vets – Professor John Innes, Mr Rob Pettitt and Mr Ben Walton. Dr. Dan Jones, who is the general Manager of Fusion Implants said, “Our future plans include working closely with our veterinary surgeon customers to provide the next generation of animal implants. In particular, we will be working on a range of hip implants to suit specific breeds.“
Investment has been provided by The North West Fund for Venture Capital, managed by Enterprise Ventures. Fusion Implants will use the funding to roll out its current product, employ a design engineer and finance new product development. Rupture of the canine cranial cruciate ligament (CCL) remains the most common orthopaedic problem seen in veterinary practices around the world and can cause knee pain and lameness. CCL surgery involves a portion of bone being removed from the tibia to allow the restructuring of the angle of the knee joint, which is subsequently held in place by an implant. The Fusion Implants team have devised a way to manufacture high-performance veterinary implants from titanium using 3D printing, or additive manufacturing as it is also known. Fusion Implants’ technology allows the mass manufacture of porous titanium material, which allows the animal’s bone to grow into the implant, forming a natural bond and improving performance considerably.
The Impact Science team provided the commercial support for the start-up process, including market research, business planning and intellectual property advice. Dr. Rhys Roberts of Impact Science said “we are very pleased that this technology has moved up to the next stage, and that we were able to introduce the Fusion Implants team to Enterprise Ventures.